MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
Mr. Soleymannezhad will lead global product development and marketing strategy for MaxCyte’s bioprocessing business.
- Mr. Soleymannezhad will lead global product development and marketing strategy for MaxCyte’s bioprocessing business.
- “With his commercial background, strategic insight and demonstrated commitment to strong financial performance, Ali will be a great addition to our executive leadership team,” said Doug Doerfler, President and CEO of MaxCyte.
- Most recently, he served as Executive Vice President for the Separations and Purification business at Tosoh Bioscience overseeing a team of 140 employees across four global manufacturing, development, and commercial sites.
- During his tenure at Tosoh, Mr. Soleymannezhad was also Vice President of Global Marketing and Business Development and Director of Sales and Marketing Americas and served on the board of Semba Biosciences.